Laborecom Therapeutics Inc.

Chicago, IL

UEI
N7XYYTZ11N47
CAGE
08B80
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1620 S Michigan Ave #418, Chicago, IL 60616, USA
Website
laborecom.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Laborecom Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A cell-permeable peptide therapeutic to reduce myocardial reperfusion injury - project summary the most deadly type of… Grant · R43HL182534 National Heart Lung and Blood Institute $845,268

Quick answers

What is Laborecom Therapeutics Inc.'s UEI?

Laborecom Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is N7XYYTZ11N47.

What is Laborecom Therapeutics Inc.'s CAGE code?

Laborecom Therapeutics Inc.'s CAGE code is 08B80.

What is Laborecom Therapeutics Inc.'s primary NAICS code?

Laborecom Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Laborecom Therapeutics Inc. located?

Laborecom Therapeutics Inc.'s physical address in SAM.gov is 1620 S Michigan Ave #418, Chicago, IL 60616, USA.

Is Laborecom Therapeutics Inc. registered in SAM.gov?

Yes. Laborecom Therapeutics Inc.'s SAM.gov registration is active through August 14, 2027.

What is Laborecom Therapeutics Inc.'s most recent federal award?

Laborecom Therapeutics Inc.'s most recent federal grant award is A cell-permeable peptide therapeutic to reduce myocardial reperfusion injury - project summary the most deadly type of… (R43HL182534), from National Heart Lung and Blood Institute, on September 15, 2025.

On GovTribe

See Laborecom Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login